Hong Kong Building Stock News

Earnings and Dividend Announcement Set the Tone Beijing Enterprises Holdings (SEHK:392) reported full year 2025 results on 26 March, with sales of CN¥87,227.8 million, net income of CN¥5,055.84 million, and a proposed final dividend of HK$0.77 per share. See our latest analysis for Beijing Enterprises Holdings. The full year 2025 earnings and dividend news comes after a mixed share price stretch, with a 2.75% 1 day share price return and 3.16% 7 day share price return sitting alongside a...

Yuexiu Property (SEHK:123) has drawn attention after reporting full year 2025 results, with sales at CN¥86,457.29 million and net income at CN¥55.06 million, sharply lower than the prior year’s CN¥1,040.06 million. See our latest analysis for Yuexiu Property. After the earnings release, Yuexiu Property’s share price at HK$3.74 reflects a 1-day share price return of 1.08%. However, the 1-year total shareholder return of 17.76% and 3-year total shareholder return of 64.20% are described as...

With the business potentially at an important milestone, we thought we'd take a closer look at Ascletis Pharma Inc.'s...

We didn't see China Health Technology Group Holding Company Limited's ( HKG:1069 ) stock surge when it reported robust...

Last week's earnings announcement from Zhonggan Communication (Group) Holdings Limited ( HKG:2545 ) was disappointing...

As Asia navigates through a landscape marked by geopolitical tensions and energy market volatility, investors are increasingly drawn to growth companies with strong insider ownership as a potential buffer against market uncertainties. In this environment, stocks that demonstrate robust revenue growth prospects while maintaining high levels of insider investment can offer appealing opportunities for those seeking stability and alignment of interests with company leadership.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have been navigating a complex landscape, with investors closely monitoring developments that could impact regional economies. Penny stocks, though often seen as relics of past investment trends, continue to offer intriguing opportunities for those looking beyond the mainstream. These stocks typically represent smaller or newer companies and can provide growth potential at lower price points when backed by strong...

Despite announcing strong earnings, Metasurface Technologies Holdings Limited's ( HKG:8637 ) stock was sluggish. Our...

Earnings jump and steady dividend put Shanghai Chicmax Cosmetic in focus Shanghai Chicmax Cosmetic (SEHK:2145) has drawn fresh attention after reporting higher full year 2025 sales and net income, alongside a proposed final dividend of RMB 0.75 per share, unchanged from 2024. See our latest analysis for Shanghai Chicmax Cosmetic. Despite the earnings and dividend news, the recent 30 day share price return of 14.81% and year to date share price return of 26.22% point to fading momentum...

Chow Tai Fook Jewellery Group has renewed its Master Leasing and Licensing Agreement with New World Development (SEHK:17) for three years from June 2026 to June 2029, maintaining a multi year commercial relationship. See our latest analysis for New World Development. The renewed agreement lands as New World Development’s share price has climbed 15.7% year to date to HK$8.55, with a 1 year total shareholder return of 95.65% contrasting with weaker 3 and 5 year total shareholder returns. If...

Phancy Group (SEHK:6682) has drawn attention after reporting full year 2025 results, with sales of CN¥7,135.29 million and a net loss of CN¥26.27 million compared with a larger loss a year earlier. See our latest analysis for Phancy Group. The latest earnings release appears to have shifted sentiment, with a 1-day share price return of 4.97% at HK$39.28 and a 1-year total shareholder return of 5.88%. However, the 90-day share price decline of 15.05% suggests recent momentum has been...

Country Garden Holdings (SEHK:2007) has reported full year 2025 results with sales of CN¥154,893 million and net income of CN¥3,261 million, alongside board-backed plans to update its Articles of Association. See our latest analysis for Country Garden Holdings. The latest results and governance updates come after a mixed share price pattern, with a 1 day share price return of 1.61% and a 90 day share price return showing a 14.86% decline, while the 5 year total shareholder return indicating a...

Wondering if Sun Hung Kai Properties at HK$138.30 is offering genuine value or just reflecting market excitement? This article walks through what the current price might be telling you. The stock has posted returns of 2.7% over the last 7 days, 1.0% over the past month, 43.2% year to date, and 116.8% over the last year, which has put it firmly on many investors' radar. Recent coverage has focused on Sun Hung Kai Properties as one of Hong Kong's large property names, with attention on how it...

Dividend changes, earnings and Kazakhstan build out put Fufeng Group in focus Fufeng Group (SEHK:546) is back on investors' radar after reporting full year 2025 results, proposing both a special and ordinary dividend, and updating progress on its Kazakhstan production base. For the year ended 31 December 2025, Fufeng Group reported sales of CN¥27,879.19 million and net income of CN¥2,465.23 million. Basic earnings per share from continuing operations were CN¥0.9833, while diluted earnings per...

MicroPort Scientific reported full-year 2025 sales of US$994.91 million and net income of US$48.52 million, while announcing that long-time chairman Dr. Zhaohua Chang stepped down as CEO and was replaced by rotating chief executive Jonathan W. Chen alongside the creation of a new Global Executive Committee and a new company secretary. This combination of a turnaround to profitability with a refreshed leadership and governance structure highlights MicroPort Scientific’s push to align...

Earnings and dividend announcement set the tone Dah Sing Banking Group (SEHK:2356) has attracted fresh attention after reporting full year 2025 results and proposing an ordinary final dividend of HK$0.49 per share, subject to shareholder approval in June 2026. See our latest analysis for Dah Sing Banking Group. The dividend and earnings news comes after a strong run, with Dah Sing Banking Group’s share price returning 6.46% over the past month and 19.96% over 90 days, while its 1-year total...

Kuaishou Technology (SEHK:1024) shares moved after the company reported quarterly and full year 2025 earnings, together with a recommended final dividend, giving investors fresh data on cash generation, shareholder returns and recent business performance. See our latest analysis for Kuaishou Technology. The latest 4.01% 1 day share price return, to HK$46.7, comes after a tougher few months, with a 30 day share price return of 22.87% decline and a 90 day share price return of 35.05% decline...

Brazilian authorities have added BYD Auto do Brasil to the country's "dirty list" of employers linked to exploitative working conditions at a Bahia plant construction project. The listing follows an investigation into labor practices at a contractor involved in building BYD's new manufacturing facility. BYD has ended its relationship with the contractor and issued public statements emphasizing its commitment to human rights. The company could now face tighter regulatory scrutiny,...

Air China has launched a new direct passenger route between Chengdu and Brussels, creating a fresh air link between China and Belgium. The service is intended to support international connectivity and contribute to the recovery of inbound tourism in Chengdu. The new route forms part of Air China’s wider international network development and aligns with local infrastructure and travel facilitation efforts. For investors tracking Air China (SEHK:753), the new Chengdu to Brussels route lands...

Phase 2 data on UBT251 puts United Laboratories International Holdings in focus United Laboratories International Holdings (SEHK:3933) drew investor attention after releasing phase 2 data for UBT251 in China, showing HbA1c and body weight reductions against placebo and semaglutide in type 2 diabetes patients. The topline readout matters because it moves UBT251 closer to late stage development, supports the start of phase 3 trials in China, and ties directly into the company’s broader diabetes...

China Mengniu Dairy (SEHK:2319) has come into focus after releasing its full year 2025 results and proposing a final ordinary dividend of RMB 0.52 per share, subject to shareholder approval. See our latest analysis for China Mengniu Dairy. The latest earnings and dividend proposal appear to have supported sentiment, with a 30 day share price return of 6.36% and a 90 day share price return of 14.41% lifting the stock to HK$17.55. This comes even though the 1 year total shareholder return is a...

China Star Entertainment (SEHK:326) just released full year 2025 results showing revenue of HK$404.92 million and a net loss of HK$443.76 million, broadly in line with guidance for a sizeable annual loss. See our latest analysis for China Star Entertainment. The weak 2025 results come after a sharp re-rating in the market, with the share price at HK$6.70 and a 30 day share price return of 45.34%. This has fed into a very large 1 year total shareholder return, suggesting momentum has been...

Simcere Pharmaceutical Group (SEHK:2096) has drawn fresh attention after reporting full year 2025 sales of CN¥7,731.41 million and net income of CN¥1,344.01 million, alongside a proposed final dividend of CN¥0.18 per share. See our latest analysis for Simcere Pharmaceutical Group. At a latest share price of HK$13.62, Simcere Pharmaceutical Group has seen a 16.91% 1 month share price return and an 80.98% 1 year total shareholder return. Recent earnings, dividend and leadership announcements...